Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jerrel L. Catlett
A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Targeting the IGF1R/PI3K/AKT Pathway Sensitizes Ewing Sarcoma to BET Bromodomain Inhibitors
Molecular Cancer Therapeutics
Cancer Research
Oncology
CDK4/6 Inhibition as Maintenance and Combination Therapy for High Grade Serous Ovarian Cancer
Oncotarget
Oncology
Targeted Combo Effective for Refractory Ewing Sarcoma
Cancer Discovery
Oncology
A Novel Tankyrase Inhibitor, MSC2504877, Enhances the Effects of Clinical CDK4/6 Inhibitors
Scientific Reports
Multidisciplinary
Preclinical Characterization of G1T28: A Novel CDK4/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression
Molecular Cancer Therapeutics
Cancer Research
Oncology
Targeted Therapy in Ewing Sarcoma
ISRN Oncology
Cdk4/6-Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status
Clinical Cancer Research
Cancer Research
Oncology
Second Malignancies in Patients Treated for Ewing Sarcoma: A Systematic Review
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
Trabectedin Efficacy in Ewing Sarcoma Is Greatly Increased by Combination With Anti-Igf Signaling Agents
Clinical Cancer Research
Cancer Research
Oncology